HIV gp120 and CD4 Binding: The Key to Viral Entry

The HIV envelope glycoprotein gp120 is the viral ligand that binds the host cell receptor CD4 on helper T lymphocytes (and macrophages, dendritic cells). This interaction initiates the entry cascade.

Stepwise Binding Process

  1. gp120-CD4 binding: gp120 (on trimeric Env spike) binds CD4 domain 1 → conformational change in gp120.
  2. Coreceptor exposure: The CD4-induced conformation reveals the V3 loop, enabling binding to a chemokine coreceptor (CCR5 for R5-tropic strains; CXCR4 for X4-tropic).
  3. gp41 activation: Coreceptor binding triggers gp41 (transmembrane subunit) to extend its fusion peptide into the host membrane.
  4. Membrane fusion: gp41 refolds into a six-helix bundle, pulling viral and cellular membranes together → fusion pore → viral core entry.

Therapeutic Targets

  • CD4 attachment inhibitors: Fostemsavir (binds gp120, blocks CD4 interaction).
  • CCR5 antagonists: Maraviroc (blocks coreceptor).
  • Fusion inhibitors: Enfuvirtide (T-20, binds gp41 HR1, prevents six-helix bundle).
  • Broadly neutralizing antibodies (bNAbs): Target conserved epitopes on gp120/gp41 (e.g., VRC01, 3BNC117).

Significance

The gp120-CD4 interaction is the gateway to infection; its plasticity allows immune evasion but also offers multiple intervention points.

HIV & AIDS - Related Articles